The effect of twelve week conjugated linoleic acid (CLA) supplementation on selected markers of atherosclerosis in obese and overweight women.

Not Applicable

• Conditions: I70; E66; Atherosclerosis; Obesity

• Registration Number: DRKS00010469
• Lead Sponsor: Department of Pediatric Gastroenterology and Metabolic DiseasesPoznan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2015-07-22
• Study Start: 2016-05-04
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 74

Inclusion Criteria

1. Female sex
2. Age greater than 18 years
3. Body mass index (BMI) = 25 kg/m2

Exclusion Criteria

1. A history of chronic systemic disease (with the exception of hypertension).
2. Celiac disease.
3. Type 2 diabetes.
4. Pancreatic and/or liver diseas.
5. Current or recent (within the preceding month) treatment with CLA or agents interfering with fat digestion and/or absorption (chitosan, orlistat, green tea)
6. Pregnancy

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
concentration of high-sensitive C-reactive protein (hs-CRP) at the study begin and after nutritional intervention

Secondary Outcome Measures

Name	Time	Method
concentration of assymetric dimethylarginine (ADMA) at the study begin and after nutritional intervention